Epidemiologists at The University of Manchester have discovered an association between the number of prescriptions for antibiotics and a higher risk of hospital admissions.

The study, published in BMC Medicine and funded by The National Institute for Health Research and the Connected Health Cities Programme, is based on the data of 2 million patients in England and Wales.

Patients who have had 9 or more antibiotic prescriptions for common infections in the previous 3 years are, say the team, 2.26 times more likely to go to hospital with another infection in three or more months.

The patient records, from 2000 to 2016, covered common infections such as upper respiratory tract, urinary tract, ear and chest infections and excluded long term conditions such as cystic fibrosis and chronic lung disease.

It not clear why hospital admissions are linked to higher prescriptions and, the team say, research is needed to show what or if any biological factors exist.

The risks of going to hospital with another infection were related to the number of the antibiotic prescriptions in the previous three years.

Patients who had 2 antibiotic prescriptions were 1.23 times more likely, patients who had 3 to 4 prescriptions 1.33 times more likely and patients who had 5 to 8 1.77 times more likely to go to hospital with another infection.

A course is defined by the team as being given over a period of one or two weeks.

Professor Tjeerd van Staa from The University of Manchester, said: "GPs care about their patients, and over recent years have worked hard to reduce the prescribing of antibiotics.

"But it is clear GPs do not have the tools to prescribe antibiotics effectively for common infections, especially when patients already have previously used antibiotics.

"They may prescribe numerous courses of antibiotics over a several years, which according to our study increases the risk of a more serious infection. That in turn, we show, is linked to hospital admissions."

He added: "We don't know why this is, but overuse of antibiotics might kill the good bacteria in the gut (microbiota) and make us more susceptible to infections, for example.

"Prescribing antibiotics for a common infection, even though it's not certain whether it's viral - where antibiotics are not indicated - or bacterial - where they are - might be easier when there is little time.

"And in a large practice, where there is no named GP, doctors may be less likely to know their patients and less tuned in to their history and circumstances to make informed decisions."

Clinical project manager Francine Jury also from The University of Manchester said: "GPs often have little time to get to grips with the detail of a patient's history.

"But what makes it even more difficult is that little official guidance exists for patients who already in the recent past had several courses of antibiotics for common infections.

"Our hope is that, however, a tool we are working for GPs, based on patient history, will be able to calculate the risks associated with taking multiple courses of antibiotics."

###

NOTES FOR EDITORS

An embargoed copy of the paper The effectiveness of frequent antibiotic use in reducing the risk of infection-related hospital admissions: results from two large population-based cohorts is available

Professor Van Staa and Francine Jury are available for comment

For media enquiries contact:

Mike Addelman

Media Relations Officer

Faculty of Biology, Medicine and Health

University of Manchester

07717 881567

The National Institute for Health Research (NIHR) is the nation's largest funder of health and care research. The NIHR:

Funds, supports and delivers high quality research that benefits the NHS, public health and social care

Engages and involves patients, carers and the public in order to improve the reach, quality and impact of research

Attracts, trains and supports the best researchers to tackle the complex health and care challenges of the future

Invests in world-class infrastructure and a skilled delivery workforce to translate discoveries into improved treatments and services

Partners with other public funders, charities and industry to maximise the value of research to patients and the economy

The NIHR was established in 2006 to improve the health and wealth of the nation through research, and is funded by the Department of Health and Social Care. In addition to its national role, the NIHR supports applied health research for the direct and primary benefit of people in low- and middle-income countries, using UK aid from the UK government.

This work uses data provided by patients and collected by the NHS as part of their care and support and would not have been possible without access to this data. The NIHR recognises and values the role of patient data, securely accessed and stored, both in underpinning and leading to improvements in research and care.

About The University of Manchester

The University of Manchester, a member of the prestigious Russell Group, is one of the UK's largest single-site university with more than 40,000 students - including more than 10,000 from overseas. It is consistently ranked among the world's elite for graduate employability. The University is also one of the country's major research institutions, rated fifth in the UK in terms of 'research power' (REF 2014). World-class research is carried out across a diverse range of fields including cancer, advanced materials, global inequalities, energy and industrial biotechnology. No fewer than 25 Nobel laureates have either worked or studied here. It is the only UK university to have social responsibility among its core strategic objectives, with staff and students alike dedicated to making a positive difference in communities around the world. Manchester is ranked 27th in the world in the QS World University Rankings 2019 and 6th in the UK.